1. Home
  2. NIU vs CDXS Comparison

NIU vs CDXS Comparison

Compare NIU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niu Technologies

NIU

Niu Technologies

HOLD

Current Price

$1.89

Market Cap

147.5M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.23

Market Cap

154.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIU
CDXS
Founded
2014
2002
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
147.5M
154.4M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
NIU
CDXS
Price
$1.89
$1.23
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$2.55
★ $6.14
AVG Volume (30 Days)
181.7K
★ 717.5K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.82
EPS
★ N/A
N/A
Revenue
N/A
★ $138,590,000.00
Revenue This Year
$20.29
$4.97
Revenue Next Year
$22.76
$18.69
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.30
52 Week Low
$1.79
$0.96
52 Week High
$4.58
$2.98

Technical Indicators

Market Signals
Indicator
NIU
CDXS
Relative Strength Index (RSI) 42.35 47.27
Support Level $1.81 $1.27
Resistance Level $2.04 $1.77
Average True Range (ATR) 0.05 0.08
MACD 0.00 0.00
Stochastic Oscillator 48.15 57.78

Price Performance

Historical Comparison
NIU
CDXS

About NIU Niu Technologies

Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: